GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Emmaus Life Sciences, Inc. (EMMA) | 8/14/2026 4:20:18 PM | View | Financials | Earnings | WIRE | 2Q 2026 | Rev $6,318,000 +124.3% | Assets $16,370,000 | EPS $0.02 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 8/14/2026 3:12:47 PM | View | Earnings | SEC | 2Q 2026 | Rev $6,318,000 +124.3% | Assets $16,370,000 | EPS $0.02 | |||
| Emmaus Life Sciences, Inc. (EMMA) | 8/14/2026 2:36:55 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $6,318,000 +124.3% | Assets $16,370,000 | EPS $0.02 | |
| Emmaus Life Sciences, Inc. (EMMA) | 5/15/2026 4:33:45 PM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $1,982,000 -17.6% | Assets $18,696,000 | EPS -$0.05 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 5/15/2026 3:13:19 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $1,982,000 -17.6% | Assets $18,696,000 | EPS -$0.05 | |
| Emmaus Life Sciences, Inc. (EMMA) | 3/31/2026 8:02:03 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $3,852,000 +17.0% | Assets $21,436,000 | EPS -$0.03 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 3/31/2026 6:24:05 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $12,453,000 -25.2% | Assets $21,436,000 | EPS -$0.12 | |
| Emmaus Life Sciences, Inc. (EMMA) | 11/14/2025 4:27:50 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $3,378,000 -38.3% | Assets $20,756,000 | EPS -$0.03 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 11/14/2025 3:21:53 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $3,378,000 -38.3% | Assets $20,756,000 | EPS -$0.03 | |
| Emmaus Life Sciences, Inc. (EMMA) | 8/14/2025 4:20:03 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $2,817,000 -47.6% | Assets $23,344,000 | EPS -$0.02 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 8/14/2025 3:13:11 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $2,817,000 -47.6% | Assets $23,344,000 | EPS -$0.02 | |
| Emmaus Life Sciences, Inc. (EMMA) | 5/15/2025 4:33:08 PM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $2,406,000 -4.0% | Assets $22,478,000 | EPS -$0.04 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 5/15/2025 4:03:16 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $2,406,000 -4.0% | Assets $22,478,000 | EPS -$0.04 | |
| Emmaus Life Sciences, Inc. (EMMA) | 4/14/2025 5:12:34 PM | View | Financials | Earnings | SEC | Y 2024 | Rev $3,292,000 -53.4% | Assets $23,602,000 | EPS -$0.03 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 4/14/2025 4:54:43 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $16,653,000 -43.7% | Assets $23,602,000 | EPS -$0.10 | |
| Emmaus Life Sciences, Inc. (EMMA) | 11/19/2024 5:11:31 PM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $5,478,000 +9.2% | Assets $27,343,000 | EPS -$0.01 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 11/19/2024 4:32:32 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $5,478,000 +9.2% | Assets $27,343,000 | EPS -$0.01 | |
| Emmaus Life Sciences, Inc. (EMMA) | 9/10/2024 5:02:48 PM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $5,377,000 -50.0% | Assets $25,939,000 | EPS -$0.03 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 9/10/2024 1:41:52 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $5,377,000 -50.0% | Assets $25,939,000 | EPS -$0.03 | |
| Emmaus Life Sciences, Inc. (EMMA) | 9/10/2024 1:31:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $2,506,000 -62.9% | Assets $29,543,000 | EPS -$0.07 | |
| Emmaus Life Sciences, Inc. (EMMA) | 7/3/2024 9:42:25 AM | View | Financials | Earnings | SEC | Y 2023 | Rev $7,067,000 +19.2% | Assets $35,179,000 | EPS $0.02 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 7/3/2024 6:19:20 AM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $29,597,000 +60.9% | Assets $35,179,000 | EPS -$0.07 | |
| Emmaus Life Sciences, Inc. (EMMA) | 11/14/2023 11:31:26 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $5,018,000 +1.6% | Assets $47,453,000 | EPS -$0.01 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 11/14/2023 6:15:09 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $5,018,000 +1.6% | Assets $47,453,000 | EPS -$0.01 | |
| Emmaus Life Sciences, Inc. (EMMA) | 8/14/2023 3:25:44 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $10,759,000 +151.0% | Assets $50,288,000 | EPS -$0.03 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 8/14/2023 2:58:26 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $10,759,000 +151.0% | Assets $50,288,000 | EPS -$0.03 | |
| Emmaus Life Sciences, Inc. (EMMA) | 5/15/2023 10:16:05 AM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $6,753,000 +108.8% | Assets $48,946,000 | EPS -$0.07 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 5/15/2023 6:40:48 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $6,753,000 +108.8% | Assets $48,946,000 | EPS -$0.07 | |
| Emmaus Life Sciences, Inc. (EMMA) | 3/31/2023 4:33:57 PM | View | Financials | Earnings | SEC | Y 2022 | Rev $5,930,000 +96.4% | Assets $48,225,000 | EPS $0.01 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 3/31/2023 3:31:58 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $18,390,000 -10.8% | Assets $48,225,000 | EPS -$0.21 | |
| Emmaus Life Sciences, Inc. (EMMA) | 11/15/2022 6:05:20 AM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $4,939,000 -14.3% | Assets $42,201,000 | EPS -$0.01 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 11/14/2022 5:09:16 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $4,939,000 -14.3% | Assets $42,201,000 | EPS -$0.01 | |
| Emmaus Life Sciences, Inc. (EMMA) | 10/31/2022 11:27:19 AM | View | Proxy | SEC | Y 2021 | ||||||
| Emmaus Life Sciences, Inc. (EMMA) | 8/15/2022 5:23:13 PM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $4,287,000 -33.9% | Assets $45,989,000 | EPS -$0.18 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 8/15/2022 3:55:16 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $4,287,000 -33.9% | Assets $45,989,000 | EPS -$0.18 | |
| Emmaus Life Sciences, Inc. (EMMA) | 7/1/2022 11:57:47 AM | Micro | View | Financials | 10-K/A | SEC | Y 2021 ending: 12/31/2021 | Rev: $20,610,000 -11.0% | Assets $56,734,000 | EPS -$0.32 | |
| Emmaus Life Sciences, Inc. (EMMA) | 5/13/2022 6:21:22 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $3,234,000 -39.4% | Assets $51,493,000 | EPS -$0.03 | |
| Emmaus Life Sciences, Inc. (EMMA) | 5/13/2022 6:18:01 AM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $3,234,000 -39.4% | Assets $51,493,000 | EPS -$0.03 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 3/31/2022 5:31:44 PM | View | Financials | Earnings | SEC | Y 2021 | Rev $3,020,000 -51.7% | Assets $56,734,000 | EPS -$0.14 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 3/31/2022 5:29:33 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $20,610,000 -11.0% | Assets $56,734,000 | EPS -$0.32 | |
| Emmaus Life Sciences, Inc. (EMMA) | 11/12/2021 2:33:14 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $5,766,000 +2.9% | Assets $60,057,000 | EPS -$0.06 | |
| Emmaus Life Sciences, Inc. (EMMA) | 11/12/2021 8:27:37 AM | View | Financials | Earnings | WIRE | 3Q 2021 | Rev $5,766,000 +2.9% | Assets $60,057,000 | EPS -$0.06 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 10/12/2021 4:17:07 PM | View | Proxy | SEC | Y 2020 | ||||||
| Emmaus Life Sciences, Inc. (EMMA) | 9/2/2021 8:50:21 AM | View | Financials | Earnings | WIRE | 2Q 2021 | Rev $6,489,000 +48.8% | Assets $63,279,000 | EPS $0.05 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 9/1/2021 3:25:21 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $6,489,000 +48.8% | Assets $63,279,000 | EPS $0.05 | |
| Emmaus Life Sciences, Inc. (EMMA) | 9/1/2021 3:25:21 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $5,335,000 -23.3% | Assets $62,223,000 | EPS -$0.17 | |
| Emmaus Life Sciences, Inc. (EMMA) | 8/26/2021 6:14:12 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $4,360,000 -20.6% | Assets $56,250,000 | EPS -$0.19 | |
| Emmaus Life Sciences, Inc. (EMMA) | 8/26/2021 6:14:12 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $5,601,000 -2.8% | Assets $59,944,000 | EPS $0.11 | |
| Emmaus Life Sciences, Inc. (EMMA) | 8/26/2021 6:14:11 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $6,954,000 +47.7% | Assets $65,992,000 | EPS $0.11 | |
| Emmaus Life Sciences, Inc. (EMMA) | 8/10/2021 6:13:23 AM | Micro | View | Financials | 10-K/A | SEC | Y 2020 ending: 12/31/2020 | Rev: $23,167,000 +1.8% | Assets $59,536,000 | EPS $0.03 | |
| Emmaus Life Sciences, Inc. (EMMA) | 5/4/2021 9:35:06 AM | View | Financials | Earnings | WIRE | Y 2020 | Rev $6,252,000 -8.0% | Assets $59,536,000 | Export Earnings Model | ||
| Emmaus Life Sciences, Inc. (EMMA) | 5/4/2021 6:15:30 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $23,167,000 +1.8% | Assets $59,536,000 | EPS $0.03 | |
| Emmaus Life Sciences, Inc. (EMMA) | 1/25/2021 12:16:34 PM | View | Financials | Earnings | WIRE | Y 2019 | Rev $6,792,000 -17.4% | Assets $59,456,000 | EPS $0.19 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 1/25/2021 6:12:25 AM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $22,752,000 +38.2% | Assets $59,456,000 | EPS -$1.30 | |
| Emmaus Life Sciences, Inc. (EMMA) | 11/13/2019 5:21:52 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $5,760,000 +18.0% | Assets $58,098,000 | EPS -$0.60 | |
| Emmaus Life Sciences, Inc. (EMMA) | 11/12/2019 8:03:43 AM | View | Financials | Earnings | WIRE | 3Q 2019 | Rev $5,760,000 +18.0% | Assets $58,098,000 | EPS -$0.60 | Export Earnings Model | |
| Emmaus Life Sciences, Inc. (EMMA) | 8/14/2019 4:23:21 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 6/30/2019 | Rev: $5,760,000 +18.0% | Assets $58,098,000 | EPS -$0.60 | |
| Emmaus Life Sciences, Inc. (EMMA) | 8/12/2019 8:11:42 AM | View | Financials | Earnings | WIRE | 3Q 2019 | Rev $5,760,000 +18.0% | Assets $58,098,000 | EPS -$0.60 | Export Earnings Model | |
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 6/14/2019 2:05:51 PM | View | Proxy | SEC | Y 2018 | ||||||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 5/14/2019 4:25:26 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $4,707,000 +502.7% | Assets $71,221,000 | EPS -$0.46 | |
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 3/21/2019 4:18:33 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $16,459,000 +3,105.6% | Assets $75,278,000 | EPS -$1.97 | |
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 11/14/2018 5:07:19 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $4,882,000 +3,379.3% | EPS -$0.13 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 8/23/2018 6:10:56 AM | View | Proxy | SEC | Y 2017 | ||||||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 8/14/2018 3:59:37 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $73,934,504 | |||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 5/15/2018 4:19:57 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $781,000 +626.7% | Assets $113,501,717 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 4/16/2018 3:13:22 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $513,447 +11.2% | Assets $123,845,472 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 11/14/2017 3:19:39 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $140,314 +126.9% | Assets $33,604,439 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 8/21/2017 5:11:29 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $118,641 -31.3% | Assets $48,423,568 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 5/12/2017 1:53:04 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $107,477 +35.4% | Assets $15,386,351 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 3/31/2017 3:59:08 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $461,591 -21.8% | Assets $12,992,578 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 11/14/2016 4:26:09 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $61,828 -19.9% | Assets $21,562,323 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 11/4/2016 2:38:35 PM | View | Proxy | SEC | Y 2015 | ||||||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 8/19/2016 3:41:13 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $172,681 +19.6% | Assets $1,263,483 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 6/6/2016 4:28:51 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $79,399 -17.9% | Assets $1,344,925 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 5/20/2016 5:21:08 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $590,114 +17.9% | Assets $1,476,998 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 5/20/2016 2:44:54 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $77,173 -50.4% | Assets $2,283,905 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 5/20/2016 2:31:14 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $144,336 +34.4% | Assets $3,447,383 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 5/20/2015 4:16:14 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $96,759 +14.3% | Assets $2,207,104 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 3/31/2015 3:21:36 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $500,679 +28.1% | Assets $2,664,292 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 11/13/2014 4:14:56 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $155,644 +135.4% | Assets $3,657,701 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 9/19/2014 2:55:02 PM | View | Proxy | SEC | Y 2013 | ||||||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 8/14/2014 2:54:58 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $107,405 +17.8% | Assets $5,820,435 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 5/20/2014 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $84,689 -5.4% | Assets $3,615,905 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 5/8/2014 2:39:47 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $390,911 -28.0% | Assets $6,113,709 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 5/8/2014 2:31:04 PM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $66,129 -41.5% | Assets $9,033,856 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 4/15/2014 8:41:56 PM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $84,689 -5.4% | Assets $3,615,905 | Export Earnings Model | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 11/14/2013 4:21:45 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $66,129 -41.5% | Assets $9,033,856 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 8/21/2013 3:11:21 PM | View | Proxy | SEC | Y 2012 | ||||||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 8/14/2013 2:14:11 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $91,208 -14.9% | Assets $3,793,341 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 5/15/2013 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $89,560 -38.3% | Assets $3,092,880 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 3/29/2013 5:24:54 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $543,058 +61.2% | Assets $2,884,240 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 11/14/2012 4:15:07 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $113,126 -25.4% | Assets $3,083,852 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 8/22/2012 7:45:00 PM | View | Proxy | SEC | Y 2011 | ||||||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 8/14/2012 2:33:05 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $107,116 +9.2% | Assets $3,314,512 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 5/14/2012 5:12:02 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $145,167 +145.2% | Assets $4,171,599 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 3/30/2012 5:30:00 AM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $336,974 +142.9% | Assets $2,482,311 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 3/14/2012 6:28:24 PM | View | Proxy | SEC | Y 2011 | ||||||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 2/24/2012 3:25:52 PM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $151,738 +606.1% | Assets $3,215,500 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 2/24/2012 3:21:18 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $98,058 | Assets $3,676,951 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 11/17/2011 5:24:28 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $98,058 | Assets $3,676,951 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 11/17/2011 5:13:19 PM | View | Financials | Earnings | SEC | 3Q 2011 | Rev $151,738 +606.1% | Assets $3,215,500 | Export Earnings Model | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 11/14/2011 4:43:21 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $151,738 +606.1% | Assets $3,215,500 | ||
| EMMAUS LIFE SCIENCES, INC. (EMMA) | 10/6/2011 4:14:06 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $98,058 | Assets $3,676,951 | ||
| EMMAUS HOLDINGS, INC. (EMMA) | 8/18/2011 4:16:40 PM | View | Financials | Earnings | SEC | 2Q 2011 | Rev $98,058 | Assets $3,676,951 | Export Earnings Model | ||
| EMMAUS HOLDINGS, INC. (EMMA) | 8/15/2011 5:31:44 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $98,058 | Assets $3,676,951 | ||
| Emmaus Life Sciences, Inc. (EMMA) | 7/1/2011 9:44:24 PM | View | Financials | Earnings | SEC | 2Q 2011 | Rev $98,058 | Assets $3,676,951 | Export Earnings Model | ||
| EMMAUS HOLDINGS, INC. (EMMA) | 5/6/2011 4:21:30 PM | View | Proxy | SEC | Y | ||||||
| EMMAUS HOLDINGS, INC. (EMMA) | 5/4/2011 5:17:19 PM | View | Financials | Earnings | SEC | Export Earnings Model |